294 related articles for article (PubMed ID: 31166593)
1. Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Ray-Zack MD; Hudgins HK; Jazzar U; Tyler DS; Freedland SJ; Swanson TA; Baillargeon JG; Hu JC; Kaul S; Kamat AM; Gore JL; Mehta HB
JAMA Surg; 2019 Aug; 154(8):e191629. PubMed ID: 31166593
[TBL] [Abstract][Full Text] [Related]
2. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
3. Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
Golla V; Shan Y; Farran EJ; Stewart CA; Vu K; Yu A; Khaki AR; Parikh DA; Swanson TA; Keegan KA; Kamat AM; Tyler DS; Freedland SJ; Williams SB
Urol Oncol; 2022 Jun; 40(6):273.e1-273.e9. PubMed ID: 35168881
[TBL] [Abstract][Full Text] [Related]
4. Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed With Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care.
Bagheri I; Shan Y; Klaassen Z; Kamat AM; Konety B; Mehta HB; Baillargeon JG; Srinivas S; Tyler DS; Swanson TA; Kaul S; Hollenbeck BK; Williams SB
Urology; 2021 Jan; 147():127-134. PubMed ID: 32980405
[TBL] [Abstract][Full Text] [Related]
5. Cost of Bladder Cancer Care: A Single-center Comparison of Radical Cystectomy and Trimodal Therapy.
Magee DE; Cheung DC; Hird AE; Chung P; Warde P; Catton C; Berlin A; Zlotta A; Fleshner NE; Kulkarni GS
Urol Pract; 2023 Jul; 10(4):293-299. PubMed ID: 37103562
[TBL] [Abstract][Full Text] [Related]
6. Use of radical cystectomy for patients with invasive bladder cancer.
Gore JL; Litwin MS; Lai J; Yano EM; Madison R; Setodji C; Adams JL; Saigal CS;
J Natl Cancer Inst; 2010 Jun; 102(11):802-11. PubMed ID: 20400716
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
[TBL] [Abstract][Full Text] [Related]
8. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
[TBL] [Abstract][Full Text] [Related]
9. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.
Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB
Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998
[TBL] [Abstract][Full Text] [Related]
10. Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research.
Bekelman JE; Handorf EA; Guzzo T; Evan Pollack C; Christodouleas J; Resnick MJ; Swisher-McClure S; Vaughn D; Ten Have T; Polsky D; Mitra N
Value Health; 2013 Jun; 16(4):610-8. PubMed ID: 23796296
[TBL] [Abstract][Full Text] [Related]
11. Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study.
Hu JC; Chughtai B; O'Malley P; Halpern JA; Mao J; Scherr DS; Hershman DL; Wright JD; Sedrakyan A
Eur Urol; 2016 Jul; 70(1):195-202. PubMed ID: 27133087
[TBL] [Abstract][Full Text] [Related]
12. Trimodal therapy for muscle-invasive bladder cancer.
Mathes J; Rausch S; Todenhöfer T; Stenzl A
Expert Rev Anticancer Ther; 2018 Dec; 18(12):1219-1229. PubMed ID: 30324833
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study.
Zheng Y; Ye Y; Chen J; Wei Z; Liu Z; Yu K; Zhang X
Int J Surg; 2022 Jul; 103():106693. PubMed ID: 35690361
[TBL] [Abstract][Full Text] [Related]
14. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.
Williams SB; Huo J; Chamie K; Hu JC; Giordano SH; Hoffman KE; Dinney CPN; Kamat AM; Shih YT
Eur Urol Focus; 2017 Apr; 3(2-3):258-264. PubMed ID: 28753760
[TBL] [Abstract][Full Text] [Related]
15. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
[TBL] [Abstract][Full Text] [Related]
16. A Nationwide, Population Based Analysis of Patients with Organ Confined, Muscle Invasive Bladder Cancer Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.
Westergren DO; Gårdmark T; Lindhagen L; Chau A; Malmström PU
J Urol; 2019 Nov; 202(5):905-912. PubMed ID: 31144594
[TBL] [Abstract][Full Text] [Related]
17. Hospital length of stay following radical cystectomy for muscle-invasive bladder cancer: Development and validation of a population-based prediction model.
Ray-Zack MD; Shan Y; Mehta HB; Yu X; Kamat AM; Williams SB
Urol Oncol; 2019 Nov; 37(11):837-843. PubMed ID: 30446462
[TBL] [Abstract][Full Text] [Related]
18. Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?
Wettstein MS; Rooprai JK; Pazhepurackel C; Wallis CJD; Klaassen Z; Uleryk EM; Hermanns T; Fleshner NE; Zlotta AR; Kulkarni GS
PLoS One; 2019; 14(4):e0216255. PubMed ID: 31034504
[TBL] [Abstract][Full Text] [Related]
19. Treatment disparities in muscle-invasive bladder cancer: Evidence from a large statewide cancer registry.
Shah AA; Sun Z; Eom KY; Grajales V; Pekala KR; Davies BJ; Jacobs BL; Sabik LM
Urol Oncol; 2022 Apr; 40(4):164.e17-164.e23. PubMed ID: 35022140
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
Shimizu F; Muto S; Taguri M; Ieda T; Tsujimura A; Sakamoto Y; Fujita K; Okegawa T; Yamaguchi R; Horie S
Int J Urol; 2017 May; 24(5):367-372. PubMed ID: 28281310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
